Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company GenSight Biologics S.A.
DescriptionGene therapy product containing undisclosed gene encoding a photoactivatable channelrhodopsin rotein, delivered via adeno-associated virus (AAV) AAV2 7m8
Molecular Target
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationRetinitis
Indication DetailsTreat retinitis pigmentosa
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today